Krankheiten, die allgemein als ansteckend oder übertragbar anerkannt sind
B20-B24 - HIV-Krankheit [Humane Immundefizienz-Viruskrankheit]
Kodierinformationen - 2019
Hinweistexte, Inklusiv- und Exklusiv- Informationen mit den Texten der Elternebenen
Inklusive (I Bestimmte infektiöse und parasitäre Krankheiten)
Exklusive (I Bestimmte infektiöse und parasitäre Krankheiten)
Keimträger oder -ausscheider, einschließlich Verdachtsfällen Z22.-
Bestimmte lokalisierte Infektionen - siehe im entsprechenden Kapitel des jeweiligen Körpersystems
Infektiöse und parasitäre Krankheiten, die Schwangerschaft, Geburt und Wochenbett komplizieren [ausgenommen Tetanus in diesem Zeitabschnitt] O98.-
Infektiöse und parasitäre Krankheiten, die spezifisch für die Perinatalperiode sind [ausgenommen Tetanus neonatorum, Keuchhusten, Syphilis connata, perinatale Gonokokkeninfektion und perinatale HIV-Krankheit] P35-P39
Grippe und sonstige akute Infektionen der Atemwege J00-J22
Hinweise
Bei den Kategorien B20-B24 sind eine oder mehrere zusätzliche Schlüsselnummern zu benutzen, um alle Manifestationen der HIV-Krankheit anzugeben. Bezüglich der Reihenfolge sind in der stationären Versorgung die Deutschen Kodierrichtlinien zu beachten.
Inklusive
AIDS-related complex [ARC]
Erworbenes Immundefektsyndrom [AIDS]
Symptomatische HIV-Infektion
Exklusive
5 untergeordnete Gruppen / Codes
In dieser Gruppe enthaltene Codes und Untergruppen.
Analyse Übersicht
Übersicht der Code Nutzung in der Marktanalyse, Patientenanalyse, G-DRG Analyse und Kalkulationsgrundlage
Mehr Details zu diesem Bereich erhalten Sie kostenfrei nach der Registrierung.
Marktanalyse
Häufigkeitsverteilung und anwendende Kliniken / Fachabteilungen
Marktanalyse der Hauptdiagnosen (ICD-10 Codes)
Das Diagramm "Nennungen als Hauptdiagnose(n) im Jahresvergleich" veranschaulicht den Trend des/der Codes in der Hauptdiagnose in den dokumentierten Krankenhausfällen.
Häufigkeitsverteilung und anwendende Kliniken / Fachabteilungen
Die folgenden Tabellen geben Aufschluss über die Einsatzhäufigkeit der Diagnosen als Hauptdiagnose (insofern eine Code Gruppe ausgewählt ist), sowie über die anwendenden Kliniken / Fachabteilungen.
Top 5 terminale Codes in dieser Gruppe
von 6 in 2006 von 7 in 2008 von 7 in 2010 von 6 in 2012 von 6 in 2013 von 6 in 2014 von 5 in 2015 von 7 in 2016 von 5 in 2017| toc | Nennungen | Gesamt Anteil |
|---|---|---|
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B23.8 open_in_new Sonstige Krankheitszustände infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheitszustände infolge HIV-Krankheit | 754 | 20,2 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B23.8 open_in_new Sonstige Krankheitszustände infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheitszustände infolge HIV-Krankheit | 743 | 28,61 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 569 | 23,51 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 584 | 27,1 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 621 | 28,11 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 585 | 27,08 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 537 | 25,43 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 523 | 25,94 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 387 | 21,37 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
Top 5 Kliniken
von 261 in 2006 von 294 in 2008 von 326 in 2010 von 297 in 2012 von 297 in 2013 von 302 in 2014 von 312 in 2015 von 308 in 2016 von 284 in 2017| Nennungen | Listenanteil | |
|---|---|---|
| xxxxxxxxx xxxxxx xx. xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| Vivantes Auguste-Viktoria-Klinikum open_in_new 12157 Berlin | 261101878-01 | 317 | 8,49 % |
| xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new insert_chart xxxxx xxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx-xxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxx xxx xxxxx... open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xx. xxxxx-xxxxxxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xx. xxxxx xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxx xxxxxxxx xxxxxxxxxx xxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new insert_chart xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx xx... open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxxx... open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxx xxxxxxxx open_in_new xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxx xxxxx xxxxxxxxxxxx xx xx... open_in_new insert_chart xxxxx xxxxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxx-xxxxxxxx-xxxxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| Charité - Universitätsmedizin Berlin open_in_new insert_chart 10117 Berlin | 261101015-00 | 211 | 8,12 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxx xxx xxxxx... open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new insert_chart xxxxx xxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new insert_chart xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx xx... open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxxxx xx. xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx-xxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxx xxxx-xxxxxxxxxxx xxxxxx ... open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxx xxxxxxxx xxxx... open_in_new insert_chart xxxxx xxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx xxx xxxx xxx xxxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx xx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxxx xxxxx - xxxxxxxxxxx... open_in_new xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxx xxx xxxxx... open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| Universitätsklinikum Essen open_in_new insert_chart 45147 Essen | 260510381-00 | 104 | 4,3 % |
| xxxxxxxx xxxxxxx-xxxxxxxx-xxxxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx xx... open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxx xxxx-xxxxxxxxxxx xxxxxx ... open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxxxx - xxxxxxxxxxx xxxx... open_in_new xxxxx xxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxxx xxxxx - xxxxxxxxxxx... open_in_new xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx xx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx xx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx-xxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx xxx xxxx xxx xxxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxxxx xx. xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new insert_chart xxxxx xxxxx | xxxxxxxxx-xx | 0 | 0 % |
| Universitätsklinikum Frankfurt open_in_new 60590 Frankfurt am Main | 260612124-00 | 61 | 2,83 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xx. xxxxx-xxxxxxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxx-xxxxxxxx-xxxxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxx xxxxxxxx xxxxxxx open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxxxx xx. xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxxxxxx - xxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxxx xxxxx - xxxxxxxxxxx... open_in_new xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx-xxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new insert_chart xxxxx xxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xx. xxxxx xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new insert_chart xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxx xxx xxxxx... open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| Universitätsklinikum Essen open_in_new insert_chart 45147 Essen | 260510381-00 | 106 | 4,8 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xx. xxxxx-xxxxxxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxx-xxxxxxxx-xxxxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx - xxxxxx... open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxxxxxx - xxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xx. xxxxx xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxxxx xx. xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx x. x. x. open_in_new xxxxx xxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxxx xxxxx - xxxxxxxxxxx... open_in_new xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxx xxx xxxxx... open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| St. Josef-Hospital Bochum open_in_new insert_chart 44791 Bochum | 260590071-01 | 65 | 3,01 % |
| xxxxxxxx xxxxxxx-xxxxxxxx-xxxxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx - xxxxxx... open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new insert_chart xxxxx xxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxxxx xx. xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxxx xxxxx - xxxxxxxxxxx... open_in_new xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xx. xxxxx xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxx xxxxxxx open_in_new xxxxx xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxxxxxx - xxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxx xxx xxxxx... open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| St. Josef-Hospital Bochum open_in_new insert_chart 44791 Bochum | 260590071-01 | 57 | 2,7 % |
| xxxxxxxx xxxxxxx-xxxxxxxx-xxxxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxxxxxx xxxxxxx - xxxxxx... open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxxxx xx. xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new insert_chart xxxxx xxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxxxxxx - xxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxx-xxxxxx xxxxxxxx xxxxxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xx. xxxxx xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx xxx xxxx xxx xxxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxx xxxxxxxx xxxx... open_in_new insert_chart xxxxx xxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxx xxxxxxxx xxxxxxx open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxx xxx xxxxx... open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| Universitätsklinikum Essen open_in_new insert_chart 45147 Essen | 260510381-00 | 52 | 2,58 % |
| xxxxxxxx xxxxxxx-xxxxxxxx-xxxxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xx. xxxxx-xxxxxxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxxx... open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxxxxxx - xxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxxxx xx. xxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new insert_chart xxxxx xxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xx. xxxxxxxxx-xxxxxxxx xxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxx xxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxxx-xxxxxxxx-xxxxxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| Universitätsklinikum Essen open_in_new insert_chart 45147 Essen | 260510381-00 | 57 | 3,15 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxx xxx xxxxx... open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxx open_in_new xxxxx xxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xx. xxxxx-xxxxxxxx xxxxxx open_in_new insert_chart xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxx xxxx xxxxx open_in_new xxxxx xxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxx open_in_new insert_chart xxxxx xxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new xxxxx xxxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx x... open_in_new xxxxx xxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx xxx xxxx xxx xxxxxxxx... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new insert_chart xxxxx xxxxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxxxxxxxxxxxxxx xxxxxxx xxxxxxx ... open_in_new xxxxx xxxxxxx | xxxxxxxxx-xx | 0 | 0 % |
| xxxxxxxx xxxxxx-xxxxx open_in_new xxxxx xxxxxx | xxxxxxxxx-xx | 0 | 0 % |
Patientenanalyse
Abrechnungsanzahl, Verteilung nach Geschlecht und Alter, sowie der Liegedauer für Hauptdiagnosen (ICD-10)
Patientenanalyse nach Hauptdiagnosen im vollstationären Bereich (ICD-10 Codes)
Das Diagramm "Fälle im Jahresvergleich" veranschaulicht den Trend des/der Codes in der Hauptdiagnose der vollstationären Krankenhausfälle.
Das Diagramm "Verteilung nach Alter und Geschlecht" zeigt die Anzahl der Fälle nach betroffenen Altersgruppen, angereichert um die Verteilung männlicher und weiblicher Patienten mit dieser(n) Hauptdiagnose(n).
Das Diagramm "Durchschnittliche Aufenthaltsdauer in Tagen" gibt Aufschluss über die durchschnittliche Verweildauer in Tagen der stationär behandelten Patienten, aufgeteilt nach Altersgruppe und Geschlecht.
Häufigkeitsverteilung
Folgende Tabelle zeigt die am häufigsten in der Hauptdiagnose verwendeten, untergeordneten Diagnosecodes.
Top 5 terminale Codes in dieser Gruppe
von 6 in 2006 von 6 in 2007 von 6 in 2008 von 6 in 2009 von 6 in 2010 von 5 in 2011 von 6 in 2012 von 5 in 2013 von 5 in 2014 von 5 in 2015 von 6 in 2016 von 5 in 2017| toc | Nennungen | Listenanteil |
|---|---|---|
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| B20 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Infektiöse und parasitäre Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 535 | 26,39 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B23.8 open_in_new Sonstige Krankheitszustände infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheitszustände infolge HIV-Krankheit | 441 | 24,2 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B23.8 open_in_new Sonstige Krankheitszustände infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheitszustände infolge HIV-Krankheit | 396 | 23,81 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 330 | 23,17 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 338 | 24,48 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B23.8 open_in_new Sonstige Krankheitszustände infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheitszustände infolge HIV-Krankheit | 348 | 26,71 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B20 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Infektiöse und parasitäre Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 373 | 28,87 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B20 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Infektiöse und parasitäre Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 407 | 31,14 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 358 | 29,76 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 312 | 29,1 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 279 | 27,25 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 189 | 20,26 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
G-DRG Analyse
Echtzuordnungen zu Fallpauschalen (DRG) aller Krankenhäuser
DRG Analyse der Diagnose (ICD-10 Codes) in der Hauptdiagnose
Das Diagramm "Top 5 DRG pro Jahr" veranschaulicht die Echt-Zuordnung zu den Fallpauschalen unter Verwendung des ICD Codes in der Hauptdiagnose. Ist eine Code Gruppe ausgewählt sind alle untergeordneten Codes inkludiert.
Häufigkeitsverteilung
Die folgende Tabelle gibt Aufschluss über die real abgerechneten Fallpauschalen (G-DRG), unter Verwendung dieses/dieser ICD-Codes (insofern eine Code Gruppe ausgewählt ist) in der Hauptdiagnose. Die Sortierung erfolgt absteigend nach Häufigkeit. Hinweis: Zuordnung Normallieger in der Hauptabteilung!
Top 5 DRG
von 9 in 2017 von 10 in 2016 von 9 in 2015| toc | Fälle | Gesamt Anteil |
|---|---|---|
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx | 0 | 0 % |
| S63B open_in_new Infektion bei HIV-Krankheit ohne komplexe Diagnose oder ohne äußerst schwere CC, ohne komplizierende Konstellation | 169 | 22,9 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxx xxxxxxxxx xxxxxxxx xxx xxxxxxx xxxxxxxx xx xxxx xxx xxxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxx xxxxxxxxxxx xxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xx | 0 | 0 % |
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx | 0 | 0 % |
| S63B open_in_new Infektion bei HIV-Krankheit ohne komplexe Diagnose oder ohne äußerst schwere CC, ohne komplizierende Konstellation | 161 | 20,91 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxx xxxxxxxxxxx xxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxx xxxxxxxxx xxxxxxxx xxx xxxxxxx xxxxxxxx xx xxxx xxx xxxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx | 0 | 0 % |
| S63B open_in_new Infektion bei HIV-Krankheit ohne komplexe Diagnose oder ohne äußerst schwere CC, ohne komplizierende Konstellation | 179 | 22,21 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxx xxx xx-xxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxx xxxxxxxxxxx xxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xx | 0 | 0 % |
Top 5 terminale Codes in dieser Gruppe
von 5 in 2017 von 6 in 2016 von 5 in 2015| toc | Fälle | Gesamt Anteil |
|---|---|---|
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B24 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Nicht näher bezeichnete HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 156 | 21,14 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 216 | 28,05 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 216 | 26,8 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
DRG Analyse der Diagnose (ICD-10 Codes) in der Nebendiagnose
Das Diagramm "Top 5 DRG pro Jahr" veranschaulicht die Echt-Zuordnung zu den Fallpauschalen unter Verwendung des ICD Codes in der Nebendiagnose. Ist eine Code Gruppe ausgewählt sind alle untergeordneten Codes inkludiert.
Häufigkeitsverteilung
Die folgende Tabelle gibt Aufschluss über die real abgerechneten Fallpauschalen (G-DRG), unter Verwendung dieses/dieser ICD-Codes (insofern eine Code Gruppe ausgewählt ist) in der Nebendiagnose. Die Sortierung erfolgt absteigend nach Häufigkeit. Hinweis: Zuordnung Normallieger in der Hauptabteilung!
Top 5 DRG
von 184 in 2017 von 222 in 2016 von 215 in 2015| toc | Codierungen | Gesamt Anteil |
|---|---|---|
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxx xxxxxxx xxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| S65B open_in_new Andere Erkrankungen bei HIV-Krankheit oder andere HIV-Krankheit ohne Herzinfarkt, außer bei chronisch ischämischer Herzkrankheit, ohne äußerst schwere CC | 1.102 | 12,46 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxxxxxxxxx xxx xxx-xxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxx xxx xx-xxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxx xxxxxxx xxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| S65B open_in_new Andere Erkrankungen bei HIV-Krankheit oder andere HIV-Krankheit ohne Herzinfarkt, außer bei chronisch ischämischer Herzkrankheit, ohne äußerst schwere CC | 1.300 | 12,85 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxxxxxxxxx xxx xxx-xxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxx xxx xx-xxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxx xxxxxxx xxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| S65B open_in_new Andere Erkrankungen bei HIV-Krankheit oder andere HIV-Krankheit ohne Herzinfarkt, außer bei chronisch ischämischer Herzkrankheit, ohne äußerst schwere CC | 1.244 | 12,2 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxxxxxxxxx xxx xxx-xxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxx xxx xx-xxxxxxxx | 0 | 0 % |
Top 5 terminale Codes in dieser Gruppe
von 6 in 2017 von 6 in 2016 von 6 in 2015| toc | Fälle | Gesamt Anteil |
|---|---|---|
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B20 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Infektiöse und parasitäre Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 2.240 | 25,32 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B20 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Infektiöse und parasitäre Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 2.414 | 23,85 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B20 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Infektiöse und parasitäre Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 2.657 | 26,07 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
Kalkulationsgrundlage
Echtzuordnungen zu Fallpauschalen (DRG) Kalkulationskrankenhäuser
DRG Analyse der Diagnose (ICD-10 Codes) in der Hauptdiagnose
Das Diagramm "Top 5 DRG pro Jahr Kalkulation" veranschaulicht die Echt-Zuordnung zu den Fallpauschalen unter Verwendung des ICD Codes in der Hauptdiagnose. Ist eine Code Gruppe ausgewählt sind alle untergeordneten Codes inkludiert.
Häufigkeitsverteilung
Die folgende Tabelle gibt Aufschluss über die real abgerechneten Fallpauschalen (G-DRG), unter Verwendung dieses/dieser ICD-Codes (insofern eine Code Gruppe ausgewählt ist) in der Hauptdiagnose. Die Sortierung erfolgt absteigend nach Häufigkeit. Hinweis: Zuordnung Normallieger in der Hauptabteilung!
Top 5 DRG
von 6 in 2017 von 6 in 2016 von 4 in 2015| toc | Fälle | Gesamt Anteil |
|---|---|---|
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx | 0 | 0 % |
| S63B open_in_new Infektion bei HIV-Krankheit ohne komplexe Diagnose oder ohne äußerst schwere CC, ohne komplizierende Konstellation | 49 | 34,03 % |
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxx xxxxxxxxx xxxxxxxx xxx xxxxxxx xxxxxxxx xx xxxx xxx xxxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxx xxx xx-xxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx | 0 | 0 % |
| S63B open_in_new Infektion bei HIV-Krankheit ohne komplexe Diagnose oder ohne äußerst schwere CC, ohne komplizierende Konstellation | 45 | 26,16 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxx xxxxxxxxx xxxxxxxx xxx xxxxxxx xxxxxxxx xx xxxx xxx xxxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxxxxxxxxx xxx xxx-xxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx | 0 | 0 % |
| S63B open_in_new Infektion bei HIV-Krankheit ohne komplexe Diagnose oder ohne äußerst schwere CC, ohne komplizierende Konstellation | 33 | 27,5 % |
| xxxx open_in_new xxxxxx xxxxxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxx xxx-xxxxxxxxx xxx xxxxxxxxxxx xxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
Top 4 terminale Codes in dieser Gruppe
von 4 in 2017 von 5 in 2016 von 4 in 2015| toc | Fälle | Gesamt Anteil |
|---|---|---|
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B23.8 open_in_new Sonstige Krankheitszustände infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheitszustände infolge HIV-Krankheit | 34 | 23,61 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B22 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 35 | 20,35 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B23.8 open_in_new Sonstige Krankheitszustände infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Sonstige näher bezeichnete Krankheitszustände infolge HIV-Krankheit | 31 | 25,83 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
DRG Analyse der Diagnose (ICD-10 Codes) in der Nebendiagnose
Das Diagramm "Top 5 DRG pro Jahr Kalkulation" veranschaulicht die Echt-Zuordnung zu den Fallpauschalen unter Verwendung des ICD Codes in der Nebendiagnose. Ist eine Code Gruppe ausgewählt sind alle untergeordneten Codes inkludiert.
Häufigkeitsverteilung
Die folgende Tabelle gibt Aufschluss über die real abgerechneten Fallpauschalen (G-DRG), unter Verwendung dieses/dieser ICD-Codes (insofern eine Code Gruppe ausgewählt ist) in der Nebendiagnose. Die Sortierung erfolgt absteigend nach Häufigkeit. Hinweis: Zuordnung Normallieger in der Hauptabteilung!
Top 5 DRG
von 67 in 2017 von 52 in 2016 von 54 in 2015| toc | Codierungen | Gesamt Anteil |
|---|---|---|
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxx xxxxxxx xxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| S65B open_in_new Andere Erkrankungen bei HIV-Krankheit oder andere HIV-Krankheit ohne Herzinfarkt, außer bei chronisch ischämischer Herzkrankheit, ohne äußerst schwere CC | 316 | 15,45 % |
| xxxx open_in_new xxxxxxxxx xxxxxxxxxx xxx xxx-xxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxx xxx xx-xxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxx xxxxxxx xxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| S65B open_in_new Andere Erkrankungen bei HIV-Krankheit oder andere HIV-Krankheit ohne Herzinfarkt, außer bei chronisch ischämischer Herzkrankheit, ohne äußerst schwere CC | 342 | 15,69 % |
| xxxx open_in_new xxxxxxxxx xxxxxxxxxx xxx xxx-xxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxx xxx xx-xxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxxxxxxxx xxx xxx-xxxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxx xxxxxxx xxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx | 0 | 0 % |
| S65B open_in_new Andere Erkrankungen bei HIV-Krankheit oder andere HIV-Krankheit ohne Herzinfarkt, außer bei chronisch ischämischer Herzkrankheit, ohne äußerst schwere CC | 277 | 14,43 % |
| xxxx open_in_new xxxxxxxxx xxxxxxxxxx xxx xxx-xxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxxx xxx xxxxxxxxxxxx | 0 | 0 % |
| xxxx open_in_new xxx-xxxxxxxxx xxx xx-xxxxxxxx | 0 | 0 % |
Top 5 terminale Codes in dieser Gruppe
von 6 in 2017 von 6 in 2016 von 6 in 2015| toc | Fälle | Gesamt Anteil |
|---|---|---|
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B20 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Infektiöse und parasitäre Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 479 | 23,42 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B24 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Nicht näher bezeichnete HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 512 | 23,49 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxx xxxxx xxxxxxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| B20 open_in_new HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] > Infektiöse und parasitäre Krankheiten infolge HIV-Krankheit [Humane Immundefizienz-Viruskrankheit] | 486 | 25,31 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
| xxx.x open_in_new xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx | 0 | 0 % |
| xxx open_in_new xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx x xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxx xxx-xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx-xxxxxxxxxxxxxxx | 0 | 0 % |
expand_less
Das sehen Sie nach der Registrierung help
| Kostenlose Basisversion | Premiumversion | |
|---|---|---|
| Basis Account | Basis Account Leistungserbringer | |
|
|
|
* Einsicht der Demoversion ** ohne Veröffentlichung
Hinweis: Zum Schutz unserer Kunden sind NUB- und Kodierhilfen-Detailansichten nur durch verifizierte Leistungserbringer einsehbar!